| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/27/2023 | 0% | Wells Fargo | $22 → $23 | Maintains | Equal-Weight |
| 09/20/2023 | 0% | Jefferies | → $23 | Initiates Coverage On | → Buy |
| 09/12/2023 | 0% | RBC Capital | $19 → $23 | Upgrades | Sector Perform → Outperform |
| 08/16/2023 | 4.35% | BMO Capital | $23.5 → $24 | Upgrades | Market Perform → Outperform |
| 07/27/2023 | 0% | Berenberg | → $23 | Initiates Coverage On | → Buy |
| 05/16/2023 | -17.39% | RBC Capital | → $19 | Reiterates | → Sector Perform |
| 05/11/2023 | -4.35% | Wells Fargo | $21 → $22 | Maintains | Equal-Weight |
| 04/20/2023 | -8.7% | Wells Fargo | → $21 | Initiates Coverage On | → Equal-Weight |
| 04/19/2023 | -8.7% | Wells Fargo | → $21 | Initiates Coverage On | → Equal-Weight |
| 02/14/2023 | -4.35% | Keybanc | $21 → $22 | Maintains | Overweight |
| 12/06/2022 | 4.35% | Raymond James | $22 → $24 | Maintains | Strong Buy |
| 11/01/2022 | -4.35% | Raymond James | $23 → $22 | Maintains | Strong Buy |
| 10/21/2022 | -17.39% | Barclays | $20 → $19 | Maintains | Equal-Weight |
| 08/08/2022 | -13.04% | Barclays | $17 → $20 | Maintains | Equal-Weight |
| 07/07/2022 | -8.7% | Keybanc | $23 → $21 | Maintains | Overweight |
| 04/27/2022 | 0% | Keybanc | $25 → $23 | Maintains | Overweight |
| 04/18/2022 | -26.09% | Barclays | $22 → $17 | Downgrades | Overweight → Equal-Weight |
| 03/18/2022 | 0% | Raymond James | $27 → $23 | Maintains | Strong Buy |
| 03/11/2022 | -13.04% | BMO Capital | → $20 | Downgrades | Outperform → Market Perform |
| 02/01/2022 | -4.35% | Credit Suisse | → $22 | Initiates Coverage On | → Neutral |
| 11/18/2021 | -4.35% | RBC Capital | $24 → $22 | Maintains | Sector Perform |
| 10/08/2021 | 0% | Baird | → $23 | Initiates Coverage On | → Outperform |
| 08/11/2021 | — | RBC Capital | Downgrades | Outperform → Sector Perform | |
| 05/24/2021 | 13.04% | RBC Capital | $24 → $26 | Maintains | Outperform |
| 01/08/2021 | 13.04% | BMO Capital | → $26 | Upgrades | Market Perform → Outperform |
| 12/14/2020 | 4.35% | Keybanc | → $24 | Upgrades | Sector Weight → Overweight |
| 12/02/2020 | — | Berenberg | Upgrades | Hold → Buy | |
| 11/11/2020 | -4.35% | RBC Capital | → $22 | Upgrades | Sector Perform → Outperform |
| 09/02/2020 | -4.35% | Stifel | → $22 | Reinstates | → Buy |
| 08/10/2020 | -4.35% | Raymond James | $21 → $22 | Maintains | Strong Buy |
| 08/03/2020 | -8.7% | Raymond James | $20 → $21 | Upgrades | Outperform → Strong Buy |
| 06/17/2020 | -8.7% | Wells Fargo | $20 → $21 | Maintains | Overweight |
| 04/29/2020 | -17.39% | Raymond James | → $19 | Upgrades | Market Perform → Outperform |
| 04/06/2020 | -43.48% | Mizuho | $19 → $13 | Upgrades | Underperform → Neutral |
| 03/26/2020 | -13.04% | Wells Fargo | $24 → $20 | Maintains | Overweight |
| 01/07/2020 | -4.35% | BMO Capital | $26 → $22 | Downgrades | Outperform → Market Perform |
| 09/03/2019 | 13.04% | Barclays | → $26 | Initiates Coverage On | → Overweight |
| 08/21/2019 | 8.7% | Capital One | → $25 | Upgrades | Equal-Weight → Overweight |
| 05/31/2019 | 8.7% | Raymond James | → $25 | Downgrades | Strong Buy → Market Perform |
| 04/09/2019 | 8.7% | BMO Capital | $22 → $25 | Maintains | Outperform |
| 01/09/2019 | — | BMO Capital | Upgrades | Market Perform → Outperform | |
| 01/08/2019 | — | Raymond James | Upgrades | Outperform → Strong Buy | |
| 12/20/2018 | — | Keybanc | Downgrades | Overweight → Sector Weight | |
| 12/04/2018 | -4.35% | Wells Fargo | $18.5 → $22 | Maintains | Outperform |
| 11/29/2018 | -8.7% | Stifel | $17 → $21 | Upgrades | Hold → Buy |
What is the target price for CareTrust REIT (CTRE)?
The latest price target for CareTrust REIT (NYSE: CTRE) was reported by Wells Fargo on November 27, 2023. The analyst firm set a price target for $23.00 expecting CTRE to fall to within 12 months (a possible 0.00% downside). 11 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for CareTrust REIT (CTRE)?
The latest analyst rating for CareTrust REIT (NYSE: CTRE) was provided by Wells Fargo, and CareTrust REIT maintained their equal-weight rating.
When is the next analyst rating going to be posted or updated for CareTrust REIT (CTRE)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of CareTrust REIT, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for CareTrust REIT was filed on November 27, 2023 so you should expect the next rating to be made available sometime around November 27, 2024.
Is the Analyst Rating CareTrust REIT (CTRE) correct?
While ratings are subjective and will change, the latest CareTrust REIT (CTRE) rating was a maintained with a price target of $22.00 to $23.00. The current price CareTrust REIT (CTRE) is trading at is $23.00, which is within the analyst's predicted range.